Elevance Health Inc (ELV)
Payables turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 287,804,000 | 283,701,000 | 279,143,000 | 271,627,000 | 265,322,000 | 259,304,000 | 252,590,000 | 243,583,000 | 233,516,000 | 226,271,000 | 219,687,000 | 209,094,000 | 204,204,000 | 196,153,000 | 188,220,000 | 186,959,000 | 179,950,000 | 174,007,000 | 168,261,000 | 163,041,200 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $287,804,000K ÷ $—K
= —
Given that the payables turnover ratio data is not provided for Elevance Health Inc across the quarters mentioned, it is not possible to conduct a detailed analysis or provide insights into the company's payables turnover performance during the specified periods. As a result, it is recommended to evaluate the company's payables turnover ratio for a specific period to assess its efficiency in managing its accounts payable and liquidity position. Understanding the payables turnover ratio can help assess a company's ability to pay its suppliers and manage its working capital effectively, providing valuable insights into its financial health.
Peer comparison
Dec 31, 2023